Respiratory Distress Syndrome
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-10Clinical Trial Update: Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome [Phase 2]
Phase 2 trial of inhaled triiodothyronine (T3) for COVID-19–associated ARDS has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-01-07Clinical Trial Update: AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial [Phase 1]
Phase 1 trial evaluating allogeneic expanded human mesenchymal stem cell therapy for acute respiratory distress syndrome in patients recover…
-
CLINICAL_TRIALS withdrawal · 2025-12-29Clinical Trial Update: Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating BX-U001, a human umbilical cord-derived mesenchymal stem cell product, for COVID-19 with Acute R…
-
CLINICAL_TRIALS withdrawal · 2025-08-20Clinical Trial Update: A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome [Phase 2]
A Phase 2 trial evaluating IC14 for acute respiratory distress syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-09Clinical Trial Update: Assessment of Occult Lung Stress During Lung Protective Mechanical Ventilation [NA]
Clinical trial assessing occult lung stress during lung-protective mechanical ventilation has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-03-18Clinical Trial Update: Glucocorticoid Therapy for Acute Respiratory Distress Syndrome [Phase 2]
A Phase 2 trial of glucocorticoid therapy for Acute Respiratory Distress Syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-24Clinical Trial Update: CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19 [Phase 1, Phase 2]
The CORONA trial evaluating DeltaRex-G gene therapy for symptomatic COVID-19 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: Stability of Driving Pressure Changes During "Best Positive End Expiratory Pressure (PEEP)" Trial
The University of Alabama at Birmingham has withdrawn a study evaluating driving pressure changes during a Best PEEP trial. The trial was co…
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS
Expanded access program for bone marrow mesenchymal stem cell-derived extracellular vesicles in COVID-19-related ARDS is no longer available…
-
CLINICAL_TRIALS withdrawal · 2024-10-31Clinical Trial Update: N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome [EARLY_Phase 1]
A clinical trial evaluating N-Acetyl-cysteine for early acute respiratory distress syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-16Clinical Trial Update: Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study [Phase 1]
A Phase 1 dose-escalation trial evaluating tenecteplase for Acute Respiratory Distress Syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-10-01Clinical Trial Update: Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19 [Phase 2]
The Phase 2 trial of cysteamine-pantetheine disulfide (TTI-0102) for mild to moderate COVID-19 has been withdrawn by the sponsor, Thiogenesi…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Confirmation of Tube Placement in Newborns [NA]
A clinical trial (NCT05229887) titled 'Confirmation of Tube Placement in Newborns' has been withdrawn. It involved Respiratory distress synd…
-
CLINICAL_TRIALS withdrawal · 2024-07-29Clinical Trial Update: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS [Phase 1, Phase 2]
The Phase 1/Phase 2 clinical trial evaluating bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for acute respiratory…
-
CLINICAL_TRIALS withdrawal · 2024-07-08Clinical Trial Update: Comparing Different Delivery Systems of Continuous Positive Airway Pressure in Neonates [NA]
A clinical trial comparing different CPAP delivery systems in neonates has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: T-Cell Mitochondrial Respiration Response to Ketone Monoester Supplement in Healthy Volunteers and COVID-19
A clinical trial studying T-cell mitochondrial respiration in response to a ketone monoester supplement in healthy volunteers and COVID-19 w…
-
CLINICAL_TRIALS withdrawal · 2024-05-06Clinical Trial Update: The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19 [Phase 2]
The ARCTIC trial investigating aerosolized inhaled adenosine for acute respiratory distress syndrome caused by COVID-19 (Phase 2) has been w…
-
CLINICAL_TRIALS withdrawal · 2024-05-02Clinical Trial Update: Early Extubation for Patients With Acute Hypoxemic Respiratory Failure [NA]
Clinical trial update indicates the study on early extubation for patients with acute hypoxemic respiratory failure, including COVID-19 pati…
-
CLINICAL_TRIALS withdrawal · 2023-07-25Clinical Trial Update: LIBERATE Trial in COVID-19 [Phase 4]
A Phase 4 clinical trial (LIBERATE) investigating COVID-19 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-02-03Clinical Trial Update: Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19 [Phase 3]
Phase 3 clinical trial of inhaled aviptadil acetate (ZYESAMI) for severe COVID-19 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-07-02Clinical Trial Update: The Use of Tadalafil in Confirmed COVID-19 Pneumonia. [Phase 4]
Phase 4 trial exploring tadalafil for confirmed COVID-19 pneumonia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-04-23Clinical Trial Update: Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome [Phase 4]
A Phase 4 trial evaluating L-Carnitine supplementation for respiratory distress syndrome in premature birth was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-03-12Clinical Trial Update: Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19) [Phase 3]
Phase 3 trial evaluating tPA for atypical ARDS in COVID-19 has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-02-12Clinical Trial Update: Autologous Umbilical Cord Blood Transfusion for Preterm Neonates [Phase 1]
A Phase 1 autologous umbilical cord blood transfusion trial in preterm neonates has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-14Clinical Trial Update: Airway Inflammatory Response During Illness in Children With Respiratory Failure
This clinical trial update indicates that the study on airway inflammatory response during illness in children with respiratory failure has …